It is the combination of three branched-chain amino acids (BCAAs) including L-leucine (2760 mg), L-isoleucine (1920 mg) and L-valine (1656 mg) combined in a sachet. Hepakast (L-leucine, L-isoleucine and L-valine) is indicated in patients suffering from different types of liver diseases including,
- Liver cirrhosis (scarring of the liver)
- Hepatic encephalopathy (Loss of brain functions which occurs due to liver damage)
- Hepatitis B and C
- Steatohepatosis (Liver inflammation caused by gathering concurrent fat in the liver)
- Post liver transplant surgery
Hepakast (L-leucine, L-isoleucine and L-valine) compensates the protein deficiency by supplementing these BCCAs (proteins are made of amino acids), as patients with cirrhosis or liver failure cannot absorb BCAAs completely from the food. It is specifically utilized in patients who cannot undertake standard therapeutic options. The absence of BCAAs renders a weakened immune system, deteriorates the mental state of the patients and leads to cognitive impairment.
Hepakast Sachet
Liver Disfunction